RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn The Peptide Craze Ground Truths The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with BPC 157 Peptide Therapy Advanced Healing & Regeneration Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest